Certificate of Suitability for the production of Piroxicam


INFA Group is pleased to announce that effective 20 January 2015, Sifavitor one of its Italian manufacturing sites, has been granted the Certificate of Suitability for the production of Piroxicam by EDQM (European Directorate for the Quality of Medicines & Health).
This attainment contributes to the already broad anti-inflammatory product range in Infa Group pipeline